108 related articles for article (PubMed ID: 12498994)
1. Evaluation of cytokeratin-19 & cytokeratin-20 and interleukin-6 in Egyptian bladder cancer patients.
El-Salahy EM
Clin Biochem; 2002 Nov; 35(8):607-13. PubMed ID: 12498994
[TBL] [Abstract][Full Text] [Related]
2. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
4. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
6. Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.
Retz M; Lehmann J; Amann E; Wullich B; Röder C; Stöckle M
J Urol; 2003 Jan; 169(1):86-9. PubMed ID: 12478110
[TBL] [Abstract][Full Text] [Related]
7. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
9. [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].
Cid Mouteira P; Ortíz Rey JA; Antón Badiola I; San Miguel Fraile P; Alvarez Alvarez C; Zungri Telo E; de la Fuente Buceta A
Actas Urol Esp; 2002 Apr; 26(4):279-84. PubMed ID: 12090187
[TBL] [Abstract][Full Text] [Related]
10. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.
Eissa S; Kassim SK; Labib RA; El-Khouly IM; Ghaffer TM; Sadek M; Razek OA; El-Ahmady O
Cancer; 2005 Apr; 103(7):1356-62. PubMed ID: 15717321
[TBL] [Abstract][Full Text] [Related]
11. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
el-Ahmady O; Halim AB; el-Din AG
Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder.
Gee JR; Montoya RG; Khaled HM; Sabichi AL; Grossman HB
Urol Oncol; 2003; 21(4):266-70. PubMed ID: 12954496
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
Chu P; Wu E; Weiss LM
Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
[TBL] [Abstract][Full Text] [Related]
14. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
[TBL] [Abstract][Full Text] [Related]
15. Association of Cytokeratin and Vimentin Protein in the Genesis of Transitional Cell Carcinoma of Urinary Bladder Patients.
Rahmani AH; Babiker AY; AlWanian WM; Elsiddig SA; Faragalla HE; Aly SM
Dis Markers; 2015; 2015():204759. PubMed ID: 26640315
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
Retz M; Lehmann J; Röder C; Weichert-Jacobsen K; Loch T; Romahn E; Lühl C; Kalthoff H; Stöckle M
Eur Urol; 2001 May; 39(5):507-15; discussion 516-7. PubMed ID: 11464030
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
19. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
20. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
